Background-Analyzing the determinants of systolic anterior motion of the mitral valve and consequent left ventricular outflow tract (LVOT) obstruction in patients with asymmetrical septal hypertrophy requires a comprehensive 3-dimensional analysis of mitral leaflet (ML) area, papillary muscle (PM) geometry, and the distribution of left ventricular hypertrophy. Methods and Results-Real-time 3-dimensional echocardiography was performed in 47 patients with asymmetrical septal hypertrophy and 32 normal controls. Patients included 20 with resting LVOT obstruction (group I) and 27 without (group II). Customized software (Omni 4D) provided a validated measure of ML surface area, LVOT area, mitral annular area and nonplanarity, LVOT hypertrophy index by topography (percent area with wall thickness Ͼ16 mm), and 3-dimensional PM positions relative to annulus. ML area was more than twice as large in group I than normal and 1.4 times normal in group II (PϽ0.001). Group I patients were also characterized by higher LVOT hypertrophy index and medial and anterior displacements of both PMs, resulting in a shorter inter-PM distance. Independent determinants of LVOT obstruction were indexed total ML area (adjusted odds ratio, 5.651; 95% confidence interval, 1.573 to 20.304; Pϭ0.008) and inter-PM distance (adjusted odds ratio, 0.416; 95% confidence interval, 0.203 to 0.854; Pϭ0.0169).
A lthough the symptomatic and survival benefit of relieving dynamic left ventricular outflow tract obstruction (LVOTO) in patients with hypertrophic cardiomyopathy (HCM) has been firmly established, 1-3 aspects of the mechanism of LVOTO remain incompletely defined. Twodimensional (2D) Doppler echocardiography confirmed individual anatomic features associated with LVOTO, including mitral valve (MV) systolic anterior motion (SAM), 4, 5 LVOT narrowing, 6 papillary muscle (PM) malposition with MV displacement, [7] [8] [9] [10] [11] [12] hyperdynamic ejection, 13 and increased mitral leaflet (ML) area. 10,14 -16 However, the relative impor-tance of PM displacement, MV malcoaptation, and septal geometry has not been quantitatively explored in a comprehensive model. The marked heterogeneity of left ventricular (LV) hypertrophy patterns in patients with HCM and asymmetrical segmental MV involvement in SAM 16 -18 inherently limit 2D echocardiography for studying LVOT determinants. Moreover, a 3-dimensional (3D) imaging technique has not been available previously for measuring ML area in vivo and correlating its changes, and hence leaflet redundancy, with changes in 3D septal and PM geometry as determinants of obstruction. To overcome these limitations, we performed a comprehensive 3D analysis including ML area, LV topography, and PM-annular relationships to determine the geometric factors associated with LVOTO in patients with asymmetrical septal hypertrophy (ASH).
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Methods
Study Population
Real-time 3D echocardiography was performed in 47 consecutive patients (aged 55Ϯ15 years; 34 men) with HCM characterized by ASH (septal thickness Ն15 mm) and images suitable for quantitative analysis. Patients included 20 with resting LVOTO (peak gradient Ն50 mm Hg; group I) and 27 without resting or provoked LVOTO (group II), with 32 healthy controls (aged 51Ϯ15 years; 19 men; normal echocardiograms and cardiovascular histories). Exclusion criteria were irregular rhythm, clinical and echocardiographic evidence of other cardiac disease (organic valvular or infiltrative), and direct PM insertion into the MV. 19 This study received institutional review board approval.
Echocardiography
Basic views were obtained with a Philips iE33 scanner with S5-1 transducer, analyzed with QLab 7.1 (Bothell, Wash), with biplane Simpson LV volumes and LVOT gradient obtained by a simplified Bernoulli equation. Real-time 3D echocardiographic parasternal and apical volumes were obtained at rest from 4 heartbeats with an X3 transducer.
ML Area
ML area was assessed at full end-diastolic leaflet opening 1 frame before closure motion with the use of custom software validated against excised valves (Omni 4D, MDH). 20 Leaflets were traced in 9 equiangular image planes rotated around an axis from LV apex to mitral annular center, with the 0°view passing through the aortic valve center, yielding 18 leaflet tracings ( Figure 1A 
Mitral Annular and Subvalvular Geometry
The medial and lateral PM tips closest to the cardiac base were determined by reviewing adjacent images. The distances and angles between the PM tips, the mitral annular centroid, and 2 relatively fixed fibrous portions of the annulus (medial and lateral trigones, defined as the end points of mitral and aortic annular intersection) were measured ( Figure 2 ). The least-squares plane of the annulus, obtained by orthogonal distance regression, was aligned with the xy plane, with the y axis aligned with the line connecting mitral and aortic centroids, about which the PMs appeared symmetrically positioned in normals; z coordinates represent apex-to-base distance. Mitral annular cross-sectional area projected onto this plane was measured at midsystole and end-diastole. 21 Annular height is the maximal distance of annular points relative to the least-squares plane. 22 
LV Topography
End-diastolic epicardial and endocardial LV boundaries were traced in 9 equiangular image planes through the LV long axis. Threedimensional wall thickness was determined as the minimum separation between endocardial and epicardial surface reconstructions with PMs excluded ( Figure 3A , panels A through C). 23, 24 The topographical distribution of regional LV wall thickness was displayed in color-coded 2D and 3D graphs, with xϭrotation angle around the ventricle along the x axis (LVOT at 180°) and yϭapex-to-base distance ( Figure 3A , panels D and E).
Normal LVs show a fairly uniform wall thickness ( Figure 3B , left), with mild variations near the right ventricular and PM insertions that were retained as consistent with the objective tracings. HCM patients typically show ASH around 180°, with a relatively thinner free wall (0°and 360°; Figure 3B ). Three indices were derived from the topographical data ( Figure 4 ): Total hypertrophy indexϭ% LV area with wall thickness arbitrarily Ͼ16 mm ( Figure  4B , red area); LVOT hypertrophy indexϭ% area Ͼ16 mm thick in the LVOT region, defined as the basal 30% of the LV (typical SAM-septal contact region) within one half of the circumference (90°to 270°; Figure 4C , where dark blueϭaortic root take-off); and mid-to-apical hypertrophy indexϭ% area Ͼ16 mm thick in the apical 50% of the LV.
LVOT Cross-Sectional Area
The minimal systolic LVOT cross-sectional area (A LVOT-SYS ) as an outcome variable reflecting LVOTO severity was determined from a parasternal 3D echocardiographic acquisition as described previous- Figure 3 . LV topography analysis. Panels A to C, In multiple planes through the ventricular axis, endocardial and epicardial boundaries are traced and reconstructed in 3 dimensions to measure wall thickness and converted to color-coded plots (panels D and E), with x axisϭrotation angle around LV long axis and y axisϭapex-to-base distance (% total length). F, Examples of wall-thickness plots from LV endocardial and epicardial surfaces (top row) in a normal control (left) and a patient with ASHϩLVOTO (right). The epicardium is shown in transparent blue to reveal the opaque endocardial surface, which is color-mapped according to wall thickness from red hues (normal) to yellow and white (increased thickness). Color-coded regional wall thickness mapped to the epicardial surfaces is displayed in 2D contours and 3D surface plots (middle and bottom rows) that display LV topography by angular position around the ventricular axis (degrees) and percent apex-to-base distance. LVOT is centered at 180°. ly 25 by translating and tilting a cutting plane orthogonal to the LVOT long axis. Pre-SAM end-diastolic LVOT area (A LVOT-DIA ) 6, 26 was measured as a potential factor contributing to SAM.
Reproducibility
All geometric parameters including ML area were measured consistently by 1 physician (Dae-Hee K.) with advanced 2D and 3D echocardiographic experience, and variability was compared with blinded measurements of a cardiac sonographer with 10 years of research experience (Y.-S.C.). Intraobserver and interobserver variability were assessed by Bland-Altman analysis, with interobserver variability by intraclass correlation coefficient between the 2 independent observers for 12 randomly selected subjects (4 from each group).
Statistical Analysis
Results are presented as meanϮSD. Normality was tested with the Shapiro-Wilk W test (PϽ0.05); nonnormal data (total hypertrophy index) were compared with a nonparametric test. Statistical significance among 3 groups was determined with 1-way ANOVA and post hoc analysis with Bonferroni correction. P values and Bonferronicorrected P values Ͻ0.05 were considered significant.
A binary logistic regression analysis was performed to find the determinants of LVOTO (present or absent). Variables with univariate PՅ0.20 were candidates for the multivariable logistic models. To minimize the overlapping meanings and overcome multicollinearity between inter-PM distance and coordinates of both PMs and their angles relative to the annulus, more clinically relevant predictor variables potentially related to LVOTO were entered into multivariable models, including left atrial dimension, indexed total ML area, indexed annular height, indexed inter-PM distance, indexed annulus area, and LVOT hypertrophy index. Backward elimination was used to develop the final multivariable model, and adjusted odds ratios with 95% confidence intervals (CIs) were calculated. Stepwise multiple linear regression analysis was used to define the predictors of A LVOT-SYS with the use of age, end-systolic LV volume, end-diastolic septal thickness, indexed total ML area, indexed annular height, indexed inter-PM distance, total hypertrophy index, and LVOT hypertrophy index. Regression diagnostics by residual plots revealed no relevant violations. Statistical analyses were performed with the use of SAS 9.1 (Cary, NC).
Results
Baseline Characteristics
Body surface area, LV volumes, and ejection fraction were not significantly different among the 3 groups (Table 1) .
Maximal septal thickness was not significantly different between ASH groups I and II, which also had no significant difference in left atrial dimension or medication use. Peak LVOT pressure gradient in group I was 89Ϯ30 mm Hg.
Mitral Annulus Geometry and ML Area
Mitral annular areas and annular height were larger in group I compared with group II and controls (Table 1) . Anterior, posterior, and total ML areas were significantly larger in patients with ASH (groups I and II) compared with normal controls, and leaflet areas were larger in patients with LVOTO (group I) than in group II ( Figure 1C through 1E ). On average, anterior and posterior ML areas in patients with LVOTO were more than twice those in controls and were 1.4 times larger in patients with ASH and no LVOTO than in controls. Total ML area correlated with body surface area (rϭ0.380, PϽ0.001), but the same significant differences among groups persisted after indexing ML areas for body surface area as well as after normalizing to mitral annular area ( Table 1) .
Subvalvular Geometry
Compared with the ASH-only group and normal controls, medial displacement of both PMs toward the center of the LV was characteristic of patients with ASH plus LVOTO ( Figure  5 , showing averaged data from each group). There was also significant anterior displacement of both PMs in the 3D annular coordinate reference frame. The midsystolic inter-PM distance was nearly 40% shorter in patients with ASH plus LVOTO than in controls and also 25% shorter than in patients without LVOTO. This resulted in reduced angles between both PMs and annular points (medial trigone and mitral centroid; Table 1 ). The distances from medial annular trigone to both PMs were mildly increased in patients with ASH versus controls but were not significantly different between those with and without LVOTO.
LV Topographical Analysis
The total LV hypertrophy index was not significantly different between groups I and II (32.1Ϯ18.8% versus 
LVOT Cross-Sectional Area
Minimal A LVOT-SYS , reflecting the combination of septal hypertrophy and SAM, was smallest in patients with LVOTO (group I) and smaller in patients without LVOTO (group II) than in controls (0.56Ϯ0.31 versus 2.75Ϯ0.66 versus 4.05Ϯ0.70 cm 2 ; PϽ0.001). A LVOT-DIA also showed similar trends (3.33Ϯ1.01 versus 5.80Ϯ1.28 versus 7.92Ϯ1.44 cm 2 ; PϽ0.001). Minimal A LVOT-SYS showed an excellent inverse correlation with peak LVOT pressure gradient in patients with ASH (exponential curve fitting, R 2 ϭ0.83, PϽ0.001; Figure 6 ).
Determinants of LVOTO and LVOT Cross-Sectional Area
Significant univariate predictors of LVOTO were annular height, annular area, inter-PM distance, PM-annular angles, ML area (total and individual leaflets), the x (mediolateral position) and y coordinates (anteroposterior position) of both PMs, and the LVOT hypertrophy index ( Table 2 ). The multivariate logistic regression model showed that the only independent determinants of LVOTO were indexed total ML area (adjusted odds ratio, 5.651; 95% CI, 1.573 to 20.304; Pϭ0.008) and inter-PM distance (adjusted odds ratio, 0.416; 95% CI, 0.203 to 0.854; Pϭ0.0169) ( Table 3 ). After stepwise multiple linear regression analysis for independent 
determinants of A LVOT-SYS (
Reproducibility
For all parameters derived from 3D tracing, including ML areas, the 2 independent observers achieved an interobserver variability of 0.94 to 0.99 (intraclass correlation coefficients) and an intraobserver variability of 0.92 to 0.98.
Discussion
This study confirmed in the beating heart the surgical and autopsy pathological findings of Klues et al 16, 26 that, on average, the area of both mitral leaflets is increased in patients with HCM and ASH compared with controls. ML area, a uniquely 3D measurement, required real-time 3D echocardiography, as did 3D PM geometry and LV topography. Although individual anatomic features have been described previously, this study ties them together in a comprehensive 3D analysis of the determinants of LVOTO in terms of ML area in the context of PM geometry, annular nonplanarity, and LV topography, all of which significantly correlated with LVOTO. Pathological changes in patients with HCM are therefore not confined to the myocardium, and primary changes of the mitral apparatus can be potential therapeutic targets.
Primary MV Changes
Since the first autopsy report of distorted MV leaflets without obvious thickening causing LVOTO, 27 anterior ML elongation was recognized as a primary abnormality in HCM by pathological examination, 28 and MV replacement was suggested as an early therapy. 29, 30 Surgical and autopsy specimens showed considerable variability in ML area in HCM patients: increased ML area in 58% (55/94), with marked asymmetrical segmental enlargement in 78% (43/55). 16 Increased ML area was subsequently associated with typical SAM, providing the slack for long leaflets to bend and move anteriorly. 26 Of note, in both the present in vivo study and the pathological study of Klues et al, 16 ML area enlargement occurs, even in patients with HCM without LVOTO, consistent with a primary MV abnormality and not secondary to LVOT obstruction or any related leaflet stretch that might occur as a result of anterior motion. The contributory role of malorientated PMs to SAM and LVOTO was postulated on the basis of angiography 7 and echocardiography. 9 The concept was that anterior displacement of the PMs should interpose the MLs into the LV outflow, which pushes the leaflets toward the septum while decreasing their normal posteriorly directed restraint. 10, [31] [32] [33] [34] Displacement of the PM tips toward each other releases tension on the leaflet center, which moves anteriorly to the greatest extent in SAM. 10, 15, 32 It is interesting to see that displacement of the lateral PM has recently become a promising target for surgical repair, 35, 36 as has PM malformation generally. 37 Increased annular nonplanarity, associated with LVOTO and LVOT area reduction in this study, also reduces ML stresses and decreases forces transmitted to them from the annulus 38, 39 ; this could further contribute to the leaflet slack necessary for SAM.
Previous 3D Echocardiographic Studies
The minimal LVOT cross-sectional area between the hypertrophied septum and the anteriorly moving SAM was the main parameter of interest in previous 3D echocardiographic studies quantifying LVOTO severity. The minimal LVOT area was abnormally small in HCM 40 and showed better inverse correlation with maximal LVOT velocity (rϭϪ0.95) than 2D SAM-septal distance (rϭϪ0.83). 25 LVOT area was also useful to assess therapeutic success. 40, 41 While confirming this relation between minimal systolic LVOT area and gradient, this study further uses 3D data to explore the mechanism of SAM at the valvular and subvalvular levels on the basis of the comprehensive geometric relationships tying together individual components contributing to SAM-septal contact. Although the presence of LVOTO was determined by leaflet area and PM separation, the systolic LVOT area, which determines the severity of obstruction, incorporates 4 pathophysiologically related features: leaflet area and annular height, both of which modulate leaflet slack and ability to move anteriorly, and PM position and LVOT hypertrophy index, which position the slack leaflets into the LV outflow, creating drag forces that propel the leaflets toward the septum.
Limitations
The mechanism of ML area increase and the reason why ML area varies for comparable degrees of LV hypertrophy cannot be determined from this study. The logical possibility that obstruction can cause leaflet stretching cannot be tested from this study. It is clear that the myocardium is not the only structure primarily affected in HCM; molecular and genetic studies are needed to relate valvular and myocardial changes. 42 Longitudinal follow-up starting before development of SAM and LVOTO might provide insights into the natural history and potential mechanism of MV changes. Although these in vivo studies and a prior pathological series both show leaflet enlargement without LVOTO, 16 ML area was not significantly different between patients with and without obstruction in that study, which may represent differences in ascertainment in a heterogeneous disease (echocardiographic referral versus surgery and autopsy) and in technique (in vivo area versus formalin-fixed excised specimens). Findings relating ML variations to mitral regurgitation in HCM have been published, 43 as have findings on the use of ML size and coaptation pattern to predict and prevent SAM after MV repair. 11, 44 The unexpected mild increase in PM-to-annular distance is consistent with hypothetical anterior rotation of a PM around its apical insertion; the decreased PM separation and increased ML area then increase slack in the anteriorly shifted leaflets, allowing anterior motion.
Clinical Implications
These findings support the concept that integrated PM-MV geometry best explains LVOT pathogenesis in patients with ASH. This is part of the growing evidence for primary structural abnormalities of the MV apparatus in HCM. 45 Considering the less than optimal results occurring in up to 20% of patients at a mean follow-up of 4 years after myectomy 46 and persistent SAM after alcohol septal ablation, 33, 47 a new way of thinking about interventional targets merits serious consideration to improve outcomes. This reconsideration should take into account the broad morphological spectrum of the condition, including concomitant increase of ML area with LV hypertrophy, representing the clinical heterogeneity of HCM. In a recent noteworthy surgical report of clinical experience with myectomy for ASH patients, an additional MV procedure was necessary in 13.5% (115/851), including MV replacement in 41.7% (48/115). 48 These findings support the need to consider mitral apparatus changes as part of therapy, with a repertoire including leaflet plication and PM reorientation. 35, 49 Because each element of PM-MV geometry can be thoroughly evaluated with the use of real-time 3D echocardiography, an individualized strategy can be applied accordingly. In summary, therefore, pathological changes in patients with HCM are not confined to the myocardium, and primary changes of the ML and subvalvular apparatus can be a potential target of new treatment options for effective relief of LVOTO. 
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